INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $0 | -100.0% | 3 | -62.5% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 8 | -38.5% | 0.00% | – |
Q2 2015 | $2,000 | -66.7% | 13 | -40.9% | 0.00% | – |
Q1 2015 | $6,000 | -83.8% | 22 | -85.3% | 0.00% | -100.0% |
Q4 2014 | $37,000 | -47.9% | 150 | -35.1% | 0.00% | -50.0% |
Q3 2014 | $71,000 | +54.3% | 231 | +23.5% | 0.00% | +100.0% |
Q2 2014 | $46,000 | +12.2% | 187 | +26.4% | 0.00% | 0.0% |
Q1 2014 | $41,000 | -90.2% | 148 | -99.4% | 0.00% | -87.5% |
Q4 2013 | $419,000 | – | 23,930 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |